(Q37857765)

24 August 2017

1 reference

title

Validated tools for evaluating opioid-induced bowel dysfunction (English)

1 reference

24 August 2017

0 references

2

Asbjørn Mohr Drewes

0 references

Anne Estrup Olesen

object named as

Anne Estrup Olesen

series ordinal

1

0 references

language of work or name

English

0 references

publication date

11 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

28

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

279-294

1 reference

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Incidence, prevalence, and management of opioid bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Constipation: evaluation and treatment of colonic and anorectal motility disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Preclinical studies of opioids and opioid antagonists on gastrointestinal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Management of opioid-induced gastrointestinal effects in patients receiving palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Effect of an enteric-release formulation of naloxone on intestinal transit in volunteers taking codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Consensus recommendations for the management of constipation in patients with advanced, progressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Treatment of opioid-induced gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

The opioid system in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Function of opioids in the enteric nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Opioid-induced bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

The ORL-1 receptor system: are there opportunities for antagonists in pain therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Insights into opioid action in the intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Kinin-induced anion-dependent secretion in porcine ileum: characterization and involvement of opioid- and cannabinoid-sensitive enteric neural circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Constipation: evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Management of opioid-induced constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Gastrointestinal side effects in chronic opioid users: results from a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Stool form scale as a useful guide to intestinal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Slow-transit constipation: solitary symptom of a systemic gastrointestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Determination of total and segmental colonic transit time in constipated patients. Results in 91 patients with a new simplified method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Blinded comparison of faecal loading on plain radiography versus radio-opaque marker transit studies in the assessment of constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Psychometric validation of a constipation symptom assessment questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

The constipation severity instrument: a validated measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Sacral nerve stimulation for intractable constipation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Development and reliability testing of the Victoria Bowel Performance Scale (BPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

Psychometric development and validation of the chronic constipation treatment satisfaction questionnaire (CTSAT-Q).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0006-4

10.1007/S12325-011-0006-4

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference